| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 50 | 2023 | 891 | 6.270 |
Why?
|
| Tobacco Smoke Pollution | 16 | 2020 | 108 | 5.340 |
Why?
|
| Electronic Nicotine Delivery Systems | 10 | 2024 | 73 | 4.820 |
Why?
|
| Tobacco Use Disorder | 9 | 2024 | 284 | 3.850 |
Why?
|
| Smoking Prevention | 7 | 2018 | 144 | 3.230 |
Why?
|
| Anti-Asthmatic Agents | 8 | 2023 | 117 | 2.400 |
Why?
|
| Tobacco Products | 6 | 2024 | 123 | 2.370 |
Why?
|
| Smoking | 13 | 2024 | 2427 | 2.210 |
Why?
|
| Vaping | 5 | 2024 | 42 | 1.960 |
Why?
|
| Tobacco Industry | 3 | 2018 | 18 | 1.760 |
Why?
|
| Adrenal Cortex Hormones | 11 | 2023 | 567 | 1.720 |
Why?
|
| Medicaid | 14 | 2023 | 305 | 1.620 |
Why?
|
| Smoking Cessation | 8 | 2024 | 755 | 1.610 |
Why?
|
| Public Policy | 3 | 2016 | 56 | 1.600 |
Why?
|
| Nicotine | 5 | 2024 | 261 | 1.280 |
Why?
|
| Palivizumab | 3 | 2018 | 61 | 1.260 |
Why?
|
| Managed Care Programs | 9 | 2023 | 84 | 1.230 |
Why?
|
| Mothers | 3 | 2016 | 418 | 1.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2015 | 261 | 1.130 |
Why?
|
| Commerce | 2 | 2016 | 65 | 1.080 |
Why?
|
| Emergency Service, Hospital | 8 | 2024 | 1230 | 1.000 |
Why?
|
| Child Health Services | 2 | 2016 | 89 | 0.990 |
Why?
|
| Respiratory Sounds | 2 | 2018 | 93 | 0.980 |
Why?
|
| Lung Injury | 2 | 2021 | 145 | 0.820 |
Why?
|
| Child | 57 | 2024 | 30373 | 0.780 |
Why?
|
| United States | 37 | 2024 | 16011 | 0.750 |
Why?
|
| Parents | 5 | 2017 | 1063 | 0.730 |
Why?
|
| Adolescent | 49 | 2023 | 32554 | 0.730 |
Why?
|
| Lung | 3 | 2021 | 3271 | 0.720 |
Why?
|
| Bupropion | 1 | 2020 | 76 | 0.690 |
Why?
|
| Varenicline | 1 | 2020 | 69 | 0.690 |
Why?
|
| Scoliosis | 2 | 2020 | 148 | 0.630 |
Why?
|
| Administration, Inhalation | 8 | 2023 | 299 | 0.620 |
Why?
|
| Drug and Narcotic Control | 1 | 2018 | 29 | 0.610 |
Why?
|
| Marketing | 1 | 2017 | 16 | 0.600 |
Why?
|
| Ozone | 2 | 2016 | 30 | 0.580 |
Why?
|
| Medical Overuse | 1 | 2017 | 50 | 0.560 |
Why?
|
| Analgesics, Non-Narcotic | 3 | 2024 | 132 | 0.560 |
Why?
|
| Pamphlets | 1 | 2016 | 33 | 0.560 |
Why?
|
| Health Policy | 2 | 2018 | 280 | 0.560 |
Why?
|
| Societies, Medical | 3 | 2021 | 1348 | 0.550 |
Why?
|
| Humans | 90 | 2024 | 271062 | 0.550 |
Why?
|
| Drug Prescriptions | 2 | 2023 | 321 | 0.520 |
Why?
|
| Environmental Exposure | 5 | 2020 | 283 | 0.520 |
Why?
|
| Air Pollutants | 3 | 2016 | 135 | 0.520 |
Why?
|
| Bronchodilator Agents | 5 | 2019 | 224 | 0.510 |
Why?
|
| Child Health | 1 | 2015 | 55 | 0.500 |
Why?
|
| Cohort Effect | 1 | 2014 | 9 | 0.480 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2017 | 215 | 0.470 |
Why?
|
| Hospitalization | 9 | 2024 | 2198 | 0.460 |
Why?
|
| Family Relations | 1 | 2014 | 88 | 0.450 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 2428 | 0.450 |
Why?
|
| Harm Reduction | 3 | 2024 | 16 | 0.440 |
Why?
|
| Patient Education as Topic | 3 | 2016 | 748 | 0.430 |
Why?
|
| Respiratory Tract Diseases | 1 | 2013 | 111 | 0.430 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2016 | 430 | 0.400 |
Why?
|
| Cotinine | 2 | 2010 | 39 | 0.400 |
Why?
|
| Fathers | 1 | 2012 | 72 | 0.390 |
Why?
|
| Analgesics, Opioid | 5 | 2024 | 1458 | 0.370 |
Why?
|
| Cystic Fibrosis | 1 | 2013 | 293 | 0.360 |
Why?
|
| Infant | 11 | 2023 | 13876 | 0.350 |
Why?
|
| Genome-Wide Association Study | 8 | 2019 | 2084 | 0.340 |
Why?
|
| Mexican Americans | 4 | 2020 | 328 | 0.340 |
Why?
|
| Sex Factors | 2 | 2014 | 2191 | 0.340 |
Why?
|
| Minority Groups | 4 | 2016 | 321 | 0.330 |
Why?
|
| Albuterol | 4 | 2018 | 74 | 0.330 |
Why?
|
| Antiviral Agents | 1 | 2016 | 1254 | 0.330 |
Why?
|
| Male | 46 | 2023 | 128516 | 0.320 |
Why?
|
| Child, Preschool | 17 | 2023 | 16930 | 0.320 |
Why?
|
| Female | 46 | 2023 | 148623 | 0.310 |
Why?
|
| Social Class | 4 | 2016 | 321 | 0.300 |
Why?
|
| Urban Population | 3 | 2016 | 281 | 0.280 |
Why?
|
| Genetic Loci | 4 | 2017 | 464 | 0.270 |
Why?
|
| Prescriptions | 2 | 2024 | 61 | 0.260 |
Why?
|
| Bronchiolitis | 2 | 2017 | 129 | 0.250 |
Why?
|
| Attitude to Health | 1 | 2008 | 437 | 0.250 |
Why?
|
| Respiratory Tract Infections | 2 | 2020 | 408 | 0.230 |
Why?
|
| Young Adult | 19 | 2020 | 22063 | 0.230 |
Why?
|
| Cultural Diversity | 1 | 2004 | 81 | 0.230 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2020 | 70 | 0.220 |
Why?
|
| Abbreviations as Topic | 1 | 2002 | 2 | 0.220 |
Why?
|
| Acute Pain | 1 | 2023 | 49 | 0.220 |
Why?
|
| Respiratory Function Tests | 3 | 2021 | 354 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2018 | 5438 | 0.210 |
Why?
|
| Administration, Oral | 2 | 2017 | 1618 | 0.210 |
Why?
|
| Vital Capacity | 2 | 2020 | 137 | 0.210 |
Why?
|
| Quality of Health Care | 2 | 2004 | 630 | 0.200 |
Why?
|
| Spirometry | 1 | 2021 | 147 | 0.180 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2023 | 1322 | 0.180 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2016 | 141 | 0.180 |
Why?
|
| Family | 2 | 2017 | 762 | 0.180 |
Why?
|
| Dangerous Behavior | 1 | 2020 | 11 | 0.180 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2020 | 46 | 0.170 |
Why?
|
| Phenotype | 2 | 2017 | 6464 | 0.170 |
Why?
|
| Allergens | 3 | 2016 | 252 | 0.170 |
Why?
|
| Primary Health Care | 2 | 2015 | 842 | 0.170 |
Why?
|
| Forced Expiratory Volume | 5 | 2019 | 320 | 0.170 |
Why?
|
| Retrospective Studies | 9 | 2024 | 39721 | 0.160 |
Why?
|
| Case-Control Studies | 10 | 2019 | 6034 | 0.160 |
Why?
|
| Infant, Newborn | 3 | 2018 | 8580 | 0.160 |
Why?
|
| Cytidine Deaminase | 1 | 2019 | 85 | 0.160 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2019 | 116 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2018 | 4328 | 0.160 |
Why?
|
| Pharmacogenomic Variants | 1 | 2018 | 28 | 0.160 |
Why?
|
| Smad2 Protein | 1 | 2018 | 91 | 0.160 |
Why?
|
| Spinal Fusion | 1 | 2020 | 150 | 0.160 |
Why?
|
| Patient Compliance | 1 | 2003 | 684 | 0.160 |
Why?
|
| Health Communication | 1 | 2018 | 35 | 0.160 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 132 | 0.160 |
Why?
|
| Telomere Homeostasis | 1 | 2018 | 70 | 0.150 |
Why?
|
| Acculturation | 1 | 2019 | 112 | 0.150 |
Why?
|
| Risk Factors | 15 | 2018 | 17829 | 0.150 |
Why?
|
| Flavoring Agents | 1 | 2017 | 3 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2018 | 185 | 0.150 |
Why?
|
| Air Pollution | 2 | 2016 | 82 | 0.150 |
Why?
|
| Peer Influence | 1 | 2017 | 4 | 0.150 |
Why?
|
| Pregnancy | 4 | 2015 | 8096 | 0.150 |
Why?
|
| Child Welfare | 1 | 1998 | 70 | 0.150 |
Why?
|
| Bronchoscopy | 1 | 2021 | 481 | 0.150 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2017 | 23 | 0.150 |
Why?
|
| Tobacco Smoking | 1 | 2017 | 37 | 0.150 |
Why?
|
| DNA, Intergenic | 1 | 2017 | 21 | 0.140 |
Why?
|
| Antiporters | 1 | 2017 | 33 | 0.140 |
Why?
|
| Skin Pigmentation | 1 | 2017 | 49 | 0.140 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 334 | 0.140 |
Why?
|
| Odds Ratio | 6 | 2016 | 2287 | 0.140 |
Why?
|
| Proteins | 2 | 2017 | 2047 | 0.140 |
Why?
|
| Cigarette Smoking | 1 | 2018 | 99 | 0.140 |
Why?
|
| Adult | 13 | 2021 | 81619 | 0.140 |
Why?
|
| Cockroaches | 1 | 2016 | 7 | 0.140 |
Why?
|
| Government Regulation | 1 | 2016 | 60 | 0.140 |
Why?
|
| Particulate Matter | 2 | 2016 | 84 | 0.140 |
Why?
|
| Needs Assessment | 1 | 2018 | 238 | 0.140 |
Why?
|
| Oxygen | 1 | 2021 | 800 | 0.140 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2016 | 68 | 0.140 |
Why?
|
| Public Health | 1 | 2019 | 298 | 0.130 |
Why?
|
| Cohort Studies | 4 | 2023 | 9438 | 0.130 |
Why?
|
| Gene-Environment Interaction | 2 | 2016 | 148 | 0.130 |
Why?
|
| RNA Splicing Factors | 1 | 2017 | 153 | 0.130 |
Why?
|
| Cost Sharing | 1 | 2016 | 7 | 0.130 |
Why?
|
| Drug Utilization | 3 | 2004 | 189 | 0.130 |
Why?
|
| Puerto Rico | 4 | 2019 | 68 | 0.130 |
Why?
|
| Emergency Medical Services | 2 | 2017 | 460 | 0.130 |
Why?
|
| Risk | 2 | 2015 | 1913 | 0.130 |
Why?
|
| Racism | 1 | 2016 | 46 | 0.130 |
Why?
|
| Maternal Age | 1 | 2016 | 146 | 0.130 |
Why?
|
| Membrane Transport Proteins | 1 | 2017 | 243 | 0.130 |
Why?
|
| Health Personnel | 1 | 2021 | 646 | 0.130 |
Why?
|
| Texas | 2 | 2017 | 6414 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 603 | 0.120 |
Why?
|
| Genotype | 4 | 2017 | 4111 | 0.120 |
Why?
|
| Telomere | 1 | 2018 | 533 | 0.120 |
Why?
|
| Breast Feeding | 1 | 2016 | 245 | 0.120 |
Why?
|
| Immunoglobulin E | 1 | 2014 | 182 | 0.120 |
Why?
|
| Minority Health | 1 | 2013 | 16 | 0.110 |
Why?
|
| Ikaros Transcription Factor | 1 | 2014 | 52 | 0.110 |
Why?
|
| Lung Diseases | 2 | 2018 | 753 | 0.110 |
Why?
|
| Health Expenditures | 1 | 2016 | 202 | 0.110 |
Why?
|
| Urban Health | 1 | 2013 | 84 | 0.110 |
Why?
|
| Prevalence | 3 | 2016 | 3417 | 0.110 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2013 | 24 | 0.110 |
Why?
|
| Stress, Psychological | 2 | 2017 | 1042 | 0.110 |
Why?
|
| Patient Readmission | 1 | 1998 | 592 | 0.110 |
Why?
|
| Emigration and Immigration | 1 | 2013 | 96 | 0.110 |
Why?
|
| Pediatrics | 2 | 2017 | 1178 | 0.100 |
Why?
|
| Infant, Premature | 1 | 2018 | 826 | 0.100 |
Why?
|
| Gestational Age | 1 | 2016 | 1151 | 0.100 |
Why?
|
| Kallikreins | 1 | 2012 | 87 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2012 | 153 | 0.100 |
Why?
|
| Age Factors | 3 | 2017 | 5487 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 1066 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2021 | 33851 | 0.100 |
Why?
|
| Obesity | 2 | 2015 | 2940 | 0.100 |
Why?
|
| Tracheitis | 1 | 1991 | 21 | 0.090 |
Why?
|
| Health Behavior | 2 | 2010 | 597 | 0.090 |
Why?
|
| Acute Disease | 1 | 2016 | 2511 | 0.090 |
Why?
|
| Algorithms | 1 | 2022 | 3907 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 1522 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2015 | 604 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2023 | 15249 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 1590 | 0.090 |
Why?
|
| Logistic Models | 5 | 2020 | 3431 | 0.090 |
Why?
|
| Analgesics | 2 | 2024 | 409 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2004 | 459 | 0.090 |
Why?
|
| Geriatric Assessment | 1 | 1991 | 291 | 0.090 |
Why?
|
| Cross-Sectional Studies | 5 | 2018 | 4507 | 0.080 |
Why?
|
| Interviews as Topic | 2 | 2017 | 520 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2018 | 6832 | 0.080 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 1038 | 0.080 |
Why?
|
| Social Support | 1 | 1991 | 587 | 0.080 |
Why?
|
| Child Day Care Centers | 1 | 2008 | 29 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 5042 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 5106 | 0.080 |
Why?
|
| Mental Health | 1 | 1991 | 416 | 0.080 |
Why?
|
| Chromosome Mapping | 3 | 2018 | 1585 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 7786 | 0.080 |
Why?
|
| State Health Plans | 2 | 2004 | 8 | 0.080 |
Why?
|
| Counseling | 1 | 2010 | 385 | 0.070 |
Why?
|
| Poverty | 3 | 2014 | 476 | 0.070 |
Why?
|
| Confidence Intervals | 2 | 2013 | 754 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2017 | 2745 | 0.070 |
Why?
|
| Aged | 4 | 2022 | 73250 | 0.070 |
Why?
|
| Intubation, Intratracheal | 1 | 1991 | 454 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2004 | 1567 | 0.070 |
Why?
|
| Creatinine | 1 | 2008 | 546 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 1991 | 682 | 0.060 |
Why?
|
| Respiratory Therapy | 1 | 2004 | 30 | 0.060 |
Why?
|
| Poisson Distribution | 1 | 2004 | 84 | 0.060 |
Why?
|
| Surveys and Questionnaires | 3 | 2016 | 5908 | 0.060 |
Why?
|
| Family Practice | 1 | 2004 | 132 | 0.060 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2024 | 103 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2016 | 1254 | 0.050 |
Why?
|
| Mental Recall | 1 | 2002 | 173 | 0.050 |
Why?
|
| Data Collection | 1 | 2004 | 622 | 0.050 |
Why?
|
| Caregivers | 1 | 2008 | 734 | 0.050 |
Why?
|
| Influenza Vaccines | 1 | 2006 | 491 | 0.050 |
Why?
|
| Linear Models | 1 | 2023 | 1092 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 30966 | 0.040 |
Why?
|
| Critical Pathways | 1 | 2001 | 158 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2004 | 4332 | 0.040 |
Why?
|
| Vaccination | 1 | 2006 | 1154 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2006 | 762 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2002 | 323 | 0.040 |
Why?
|
| Health Status | 1 | 2002 | 632 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2002 | 364 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 473 | 0.040 |
Why?
|
| Educational Status | 2 | 2013 | 390 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2016 | 2237 | 0.040 |
Why?
|
| Louisiana | 1 | 1997 | 144 | 0.040 |
Why?
|
| Sulfur Dioxide | 1 | 2016 | 6 | 0.030 |
Why?
|
| Communication | 1 | 2003 | 856 | 0.030 |
Why?
|
| Geography, Medical | 1 | 2016 | 22 | 0.030 |
Why?
|
| Nitrogen Dioxide | 1 | 2016 | 17 | 0.030 |
Why?
|
| Public Health Surveillance | 1 | 2016 | 64 | 0.030 |
Why?
|
| Focus Groups | 1 | 2017 | 285 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2018 | 296 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2004 | 1323 | 0.030 |
Why?
|
| Leukotriene Antagonists | 1 | 2015 | 17 | 0.030 |
Why?
|
| Education, Nonprofessional | 1 | 2015 | 5 | 0.030 |
Why?
|
| Pain | 1 | 2024 | 1696 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 788 | 0.030 |
Why?
|
| HLA-DQ alpha-Chains | 1 | 2014 | 23 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2003 | 1229 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 404 | 0.030 |
Why?
|
| Immunization | 1 | 2016 | 403 | 0.030 |
Why?
|
| San Francisco | 1 | 2013 | 22 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2017 | 628 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 533 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2016 | 310 | 0.030 |
Why?
|
| Disease Progression | 2 | 2016 | 6898 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2014 | 287 | 0.030 |
Why?
|
| Middle Aged | 1 | 2020 | 90103 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2013 | 104 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2014 | 185 | 0.030 |
Why?
|
| Global Health | 1 | 2018 | 695 | 0.030 |
Why?
|
| Skin Tests | 1 | 2013 | 102 | 0.030 |
Why?
|
| Income | 1 | 2013 | 228 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2016 | 648 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2012 | 92 | 0.020 |
Why?
|
| Institutionalization | 1 | 1991 | 17 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 256 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2013 | 263 | 0.020 |
Why?
|
| Personality Inventory | 1 | 1991 | 197 | 0.020 |
Why?
|
| Personal Satisfaction | 1 | 1991 | 124 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2014 | 663 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2018 | 2089 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 2507 | 0.020 |
Why?
|
| Feedback | 1 | 2010 | 227 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 1436 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2004 | 13375 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2010 | 266 | 0.020 |
Why?
|
| Disease Management | 1 | 2014 | 1111 | 0.020 |
Why?
|
| Incidence | 1 | 2018 | 5842 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 1991 | 566 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 2350 | 0.020 |
Why?
|
| Genome, Human | 1 | 2014 | 1834 | 0.020 |
Why?
|
| Breathing Exercises | 1 | 2004 | 23 | 0.010 |
Why?
|
| Long-Term Care | 1 | 2004 | 85 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 4389 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2003 | 423 | 0.010 |
Why?
|
| Vulnerable Populations | 1 | 2003 | 185 | 0.010 |
Why?
|
| Malnutrition | 1 | 2004 | 225 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2004 | 583 | 0.010 |
Why?
|
| Sleep Wake Disorders | 1 | 2004 | 371 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2014 | 5497 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 13112 | 0.010 |
Why?
|
| Terminal Care | 1 | 2004 | 465 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 1851 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2004 | 738 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 36039 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 62826 | 0.010 |
Why?
|